![](https://www.realrate-archive.com/us_pharma/logos/0001010086_256x256.png) | 1 | SIGA TECHNOLOGIES INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 394.00% | 304.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001411906_256x256.png) | 2 | Ampio Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 376.73% | 320.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001410939_256x256.png) | 3 | IVERIC bio Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 367.49% | 152.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 4 | BIOSPECIFICS TECHNOLOGIES CORP | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 366.30% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/zero-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 5 | SPRING PHARMACEUTICAL GROUP INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 359.53% | 1.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001177648_256x256.png) | 6 | ENANTA PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 344.52% | 3.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001413754_256x256.png) | 7 | MARIZYME INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 341.24% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 8 | XYNOMIC PHARMACEUTICALS HOLDINGS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 336.62% | -3.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 9 | Viking Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 319.26% | 225.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001157601_256x256.png) | 10 | MADRIGAL PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 318.89% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001088856_256x256.png) | 11 | CORCEPT THERAPEUTICS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 316.50% | -8.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001232524_256x256.png) | 12 | Jazz Pharmaceuticals plc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 316.25% | -5.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 13 | ARENA PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 307.08% | 72.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001370053_256x256.png) | 14 | ANAPTYSBIO INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 292.51% | -4.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000886744_256x256.png) | 15 | GERON CORP | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 289.05% | 9.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 16 | Equillium Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 283.73% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001510964_256x256.png) | 17 | CV Sciences Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 282.92% | 95.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 18 | ARATANA THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 282.83% | 153.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000906709_256x256.png) | 19 | NEKTAR THERAPEUTICS | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 281.36% | 219.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 20 | Principia Biopharma Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 280.59% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001560241_256x256.png) | 21 | G1 Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 277.22% | 77.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001226616_256x256.png) | 22 | MEDICINOVA INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 273.11% | 13.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001253689_256x256.png) | 23 | GLYCOMIMETICS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 272.17% | 4.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001082554_256x256.png) | 24 | UNITED THERAPEUTICS Corp | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 271.62% | 18.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 25 | TENAX THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 271.61% | -12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001124105_256x256.png) | 26 | GYRE THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 271.37% | 119.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000318306_256x256.png) | 27 | ABEONA THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 270.58% | -15.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001596783_256x256.png) | 28 | Catalent Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 269.34% | -7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000827871_256x256.png) | 29 | EAGLE PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 268.81% | -12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 30 | ACHILLION PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 267.42% | -12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000001800_256x256.png) | 31 | ABBOTT LABORATORIES | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 267.27% | -15.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001069530_256x256.png) | 32 | CASSAVA SCIENCES INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 263.47% | 147.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001326732_256x256.png) | 33 | Xencor Inc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 261.89% | 59.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001422142_256x256.png) | 34 | Aadi Bioscience Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 260.16% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 35 | MyoKardia Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 256.68% | 3.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001347178_256x256.png) | 36 | Vanda Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 256.64% | 83.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 37 | RENOVARO BIOSCIENCES INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 254.63% | 204.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 38 | ZOGENIX INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 252.10% | -12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 39 | Ra Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 251.86% | 97.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001674365_256x256.png) | 40 | Aptinyx Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 251.41% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001485003_256x256.png) | 41 | Carisma Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 250.99% | -7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001722964_256x256.png) | 42 | Y-mAbs Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 243.10% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000812306_256x256.png) | 43 | PROCYON CORP | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 241.29% | -14.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 44 | Provention Bio Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 240.17% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001401040_256x256.png) | 45 | DiaMedica Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 239.65% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000872589_256x256.png) | 46 | REGENERON PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 237.96% | 8.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001540159_256x256.png) | 47 | Edesa Biotech Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 234.23% | 26.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001126234_256x256.png) | 48 | LUMOS PHARMA INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 234.19% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001113148_256x256.png) | 49 | INFINITY PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 232.40% | 108.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001117480_256x256.png) | 50 | CHIMERIX INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 232.00% | -22.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001566044_256x256.png) | 51 | VYNE Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 231.18% | 69.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001724344_256x256.png) | 52 | Entasis Therapeutics Holdings Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 229.14% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 53 | Corvus Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 226.50% | 44.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001404644_256x256.png) | 54 | Neoleukin Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 226.36% | 12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001724521_256x256.png) | 55 | Arcus Biosciences Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 225.13% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001447028_256x256.png) | 56 | Arbutus Biopharma Corp | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 224.87% | 59.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001645469_256x256.png) | 57 | Monopar Therapeutics | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 224.70% | 188.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 58 | NANOVIRICIDES INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 224.61% | 66.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001701108_256x256.png) | 59 | Spero Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 221.72% | -7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 60 | LIXTE BIOTECHNOLOGY HOLDINGS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 218.28% | 195.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001042074_256x256.png) | 61 | CymaBay Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 217.22% | 9.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001708599_256x256.png) | 62 | AgeX Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 216.50% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001593034_256x256.png) | 63 | Endo International plc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 215.72% | -6.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001367920_256x256.png) | 64 | CONCERT PHARMACEUTICALS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 214.05% | -62.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 65 | Neurotrope Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 213.31% | 64.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001597553_256x256.png) | 66 | Sage Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 213.19% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 67 | Kura Oncology Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 212.40% | 13.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001527599_256x256.png) | 68 | SYNLOGIC INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 210.73% | 11.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000310158_256x256.png) | 69 | Merck & Co. Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 209.78% | -32.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 70 | FIVE PRIME THERAPEUTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 209.44% | 14.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001544227_256x256.png) | 71 | Tempest Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 207.51% | 52.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001730430_256x256.png) | 72 | Kiniksa Pharmaceuticals Ltd. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 206.83% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 73 | Citius Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 206.76% | -12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001496671_256x256.png) | 74 | Calithera Biosciences Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 205.87% | -7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001551152_256x256.png) | 75 | AbbVie Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 204.32% | -35.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001092662_256x256.png) | 76 | CHEMBIO DIAGNOSTICS INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 203.84% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001582313_256x256.png) | 77 | Xenon Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 202.27% | 83.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 78 | Strongbridge Biopharma plc | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 198.70% | 213.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001463361_256x256.png) | 79 | Unity Biotechnology Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 197.96% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001720893_256x256.png) | 80 | BioXcel Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 197.55% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001567514_256x256.png) | 81 | Intra-Cellular Therapies Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 197.33% | -67.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 82 | Evelo Biosciences Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 195.42% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001576263_256x256.png) | 83 | Mirati Therapeutics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 194.49% | -27.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001070494_256x256.png) | 84 | ACADIA PHARMACEUTICALS INC | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 192.52% | 57.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000875320_256x256.png) | 85 | VERTEX PHARMACEUTICALS INC MA | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 190.59% | 41.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 86 | Theriva Biologics Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 189.68% | 163.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 87 | Cocrystal Pharma Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 187.94% | -64.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000944809_256x256.png) | 88 | OPKO HEALTH INC. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 187.61% | -5.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001533040_256x256.png) | 89 | Phio Pharmaceuticals Corp. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 187.44% | 230.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001297184_256x256.png) | 90 | Amphastar Pharmaceuticals Inc. | ![](https://realrate.ai/wp-content/themes/flatsome-child/table-images/top-rated-01.svg) | 186.96% | -32.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 91 | IMMUNE DESIGN CORP. | | 186.80% | -48.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001377121_256x256.png) | 92 | Protagonist Therapeutics Inc | | 183.73% | 13.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001267602_256x256.png) | 93 | ALIMERA SCIENCES INC | | 183.35% | -15.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 94 | OncoMed Pharmaceuticals Inc | | 182.36% | 189.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001571498_256x256.png) | 95 | Epizyme Inc. | | 182.01% | -35.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000768710_256x256.png) | 96 | RELIV INTERNATIONAL INC | | 180.18% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/zero-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001107421_256x256.png) | 97 | Alaunos Therapeutics Inc. | | 179.94% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 98 | ARQULE INC | | 179.04% | 48.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001403752_256x256.png) | 99 | Zymeworks BC Inc. | | 177.71% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001583107_256x256.png) | 100 | Theravance Biopharma Inc. | | 175.73% | 28.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001661998_256x256.png) | 101 | Homology Medicines Inc. | | 171.70% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001048477_256x256.png) | 102 | BIOMARIN PHARMACEUTICAL INC | | 171.31% | 25.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000879407_256x256.png) | 103 | ARROWHEAD PHARMACEUTICALS INC. | | 170.87% | 4.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001445283_256x256.png) | 104 | KINETA INC. DE | | 170.74% | 65.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001651308_256x256.png) | 105 | BeiGene Ltd. | | 170.68% | 12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 106 | ALEXION PHARMACEUTICALS INC. | | 169.58% | -7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001715611_256x256.png) | 107 | BODY & MIND INC. | | 169.10% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001281895_256x256.png) | 108 | ROCKET PHARMACEUTICALS INC. | | 167.97% | 85.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001426800_256x256.png) | 109 | ASSEMBLY BIOSCIENCES INC. | | 166.91% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000818033_256x256.png) | 110 | HERON THERAPEUTICS INC. DE | | 165.21% | 125.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001005286_256x256.png) | 111 | LIFECORE BIOMEDICAL INC. \DE\ | | 165.09% | -5.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001082038_256x256.png) | 112 | DURECT CORP | | 164.75% | -21.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001636282_256x256.png) | 113 | Aeglea BioTherapeutics Inc. | | 162.78% | -42.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001439222_256x256.png) | 114 | AGIOS PHARMACEUTICALS INC. | | 162.46% | 69.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001178670_256x256.png) | 115 | ALNYLAM PHARMACEUTICALS INC. | | 160.04% | -79.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 116 | Molecular Templates Inc. | | 159.71% | -67.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 117 | Aimmune Therapeutics Inc. | | 159.64% | 4.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001476963_256x256.png) | 118 | NightHawk Biosciences Inc. | | 158.68% | 138.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001454789_256x256.png) | 119 | Astria Therapeutics Inc. | | 157.76% | 158.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000275053_256x256.png) | 120 | NATURES SUNSHINE PRODUCTS INC | | 156.62% | 13.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001360214_256x256.png) | 121 | HARROW INC. | | 154.27% | 145.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 122 | Allergan plc | | 154.11% | -4.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001621443_256x256.png) | 123 | Zynerba Pharmaceuticals Inc. | | 153.57% | -48.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001369568_256x256.png) | 124 | CATALYST PHARMACEUTICALS INC. | | 152.13% | -105.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001124524_256x256.png) | 125 | Cryoport Inc. | | 151.94% | -63.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 126 | GW PHARMACEUTICALS PLC | | 147.93% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001655759_256x256.png) | 127 | ARVINAS INC. | | 147.76% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000831547_256x256.png) | 128 | SPECTRUM PHARMACEUTICALS INC | | 146.82% | -27.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001597264_256x256.png) | 129 | Blueprint Medicines Corp | | 146.42% | -107.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001460602_256x256.png) | 130 | Orgenesis Inc. | | 146.03% | 68.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001034842_256x256.png) | 131 | RIGEL PHARMACEUTICALS INC | | 143.86% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001326190_256x256.png) | 132 | Altimmune Inc. | | 142.82% | 35.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001739104_256x256.png) | 133 | Elanco Animal Health Inc | | 141.80% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001557746_256x256.png) | 134 | Aclaris Therapeutics Inc. | | 141.29% | -102.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001517022_256x256.png) | 135 | Akebia Therapeutics Inc. | | 140.04% | 82.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 136 | Intec Pharma Ltd. | | 139.78% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001556263_256x256.png) | 137 | Syros Pharmaceuticals Inc. | | 139.02% | 6.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001615999_256x256.png) | 138 | NEUROPATHIX INC. | | 136.60% | 190.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001668243_256x256.png) | 139 | UroGen Pharma Ltd. | | 135.54% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 140 | CAMBREX CORP | | 134.72% | -99.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001322505_256x256.png) | 141 | ALBIREO PHARMA INC. | | 134.09% | -96.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001493566_256x256.png) | 142 | OTONOMY INC. | | 133.31% | -29.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001106644_256x256.png) | 143 | CHINA PHARMA HOLDINGS INC. | | 132.54% | -11.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001374690_256x256.png) | 144 | Larimar Therapeutics Inc. | | 131.87% | 5.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001680048_256x256.png) | 145 | MUSTANG BIO INC. | | 130.07% | -99.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 146 | Pfenex Inc. | | 129.29% | -21.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001176309_256x256.png) | 147 | ORAMED PHARMACEUTICALS INC. | | 128.56% | 34.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001160308_256x256.png) | 148 | Savara Inc | | 126.55% | -59.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000873303_256x256.png) | 149 | Sarepta Therapeutics Inc. | | 125.56% | -18.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001622229_256x256.png) | 150 | Cogent Biosciences Inc. | | 123.76% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001626199_256x256.png) | 151 | ALPINE IMMUNE SCIENCES INC. | | 123.50% | -136.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001492422_256x256.png) | 152 | Apellis Pharmaceuticals Inc. | | 121.34% | -78.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001261249_256x256.png) | 153 | AGILE THERAPEUTICS INC | | 121.25% | 10.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001590560_256x256.png) | 154 | uniQure N.V. | | 121.12% | 61.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001585364_256x256.png) | 155 | PERRIGO Co plc | | 120.21% | -8.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001559053_256x256.png) | 156 | PROTHENA CORP PUBLIC LTD CO | | 118.56% | -79.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001356576_256x256.png) | 157 | SUPERNUS PHARMACEUTICALS INC. | | 118.33% | -71.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000887247_256x256.png) | 158 | DMK PHARMACEUTICALS Corp | | 117.97% | -18.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001125345_256x256.png) | 159 | MACROGENICS INC | | 116.90% | -115.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000704562_256x256.png) | 160 | Avid Bioservices Inc. | | 116.40% | 27.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000764195_256x256.png) | 161 | VBI Vaccines Inc BC | | 115.86% | -98.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001582554_256x256.png) | 162 | Matinas BioPharma Holdings Inc. | | 115.23% | 62.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 163 | Cellectar Biosciences Inc. | | 113.61% | 32.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000886163_256x256.png) | 164 | LIGAND PHARMACEUTICALS INC | | 112.99% | -50.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001598646_256x256.png) | 165 | Minerva Neurosciences Inc. | | 111.79% | -61.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001368148_256x256.png) | 166 | ATHERSYS INC NEW | | 111.74% | 104.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 167 | NEXIEN BIOPHARMA INC. | | 110.57% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 168 | AKCEA THERAPEUTICS INC. | | 110.27% | -10.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000874015_256x256.png) | 169 | IONIS PHARMACEUTICALS INC | | 110.22% | 28.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001178253_256x256.png) | 170 | SCYNEXIS INC | | 109.80% | 51.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000849146_256x256.png) | 171 | Lifevantage Corp | | 108.45% | 19.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001522602_256x256.png) | 172 | CohBar Inc. | | 108.04% | 24.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001023024_256x256.png) | 173 | ANI PHARMACEUTICALS INC | | 106.82% | 1.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001396814_256x256.png) | 174 | Pacira BioSciences Inc. | | 104.42% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000014272_256x256.png) | 175 | BRISTOL MYERS SQUIBB CO | | 104.41% | 7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001087294_256x256.png) | 176 | CUMBERLAND PHARMACEUTICALS INC | | 104.28% | -74.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001367083_256x256.png) | 177 | Sonoma Pharmaceuticals Inc. | | 104.24% | -169.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001534525_256x256.png) | 178 | Xenetic Biosciences Inc. | | 102.90% | -85.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 179 | MERRIMACK PHARMACEUTICALS INC | | 102.58% | -178.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001659617_256x256.png) | 180 | Moleculin Biotech Inc. | | 101.93% | -98.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001682639_256x256.png) | 181 | EYENOVIA INC. | | 101.68% | -27.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000748592_256x256.png) | 182 | Eterna Therapeutics Inc. | | 101.41% | 17.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001383701_256x256.png) | 183 | Histogen Inc. | | 101.32% | -44.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 184 | Tonix Pharmaceuticals Holding Corp. | | 100.77% | -62.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 185 | Kadmon Holdings Inc. | | 97.37% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000200406_256x256.png) | 186 | JOHNSON & JOHNSON | | 95.20% | -10.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000078003_256x256.png) | 187 | PFIZER INC | | 93.97% | -25.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000891293_256x256.png) | 188 | CTI BIOPHARMA CORP | | 93.96% | 76.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001739426_256x256.png) | 189 | RVL Pharmaceuticals plc | | 92.01% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001318641_256x256.png) | 190 | Statera Biopharma Inc. | | 91.99% | 24.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001385818_256x256.png) | 191 | AYTU BIOPHARMA INC | | 89.92% | 99.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 192 | PROGENICS PHARMACEUTICALS INC | | 89.24% | 21.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001437402_256x256.png) | 193 | ARDELYX INC. | | 86.03% | -128.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 194 | Dicerna Pharmaceuticals Inc | | 83.04% | -84.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000057725_256x256.png) | 195 | LANNETT CO INC | | 82.98% | -6.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001438533_256x256.png) | 196 | Travere Therapeutics Inc. | | 80.81% | -44.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 197 | Dova Pharmaceuticals Inc. | | 79.81% | -41.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000863894_256x256.png) | 198 | VERU INC. | | 79.41% | -167.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001497504_256x256.png) | 199 | PLx Pharma Winddown Corp. | | 79.00% | 66.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 200 | Mylan II B.V. | | 77.83% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001570562_256x256.png) | 201 | Evolus Inc. | | 75.80% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001698530_256x256.png) | 202 | EXICURE INC. | | 74.53% | -43.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001659323_256x256.png) | 203 | Iterum Therapeutics plc | | 74.34% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001479290_256x256.png) | 204 | Revance Therapeutics Inc. | | 70.27% | -156.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001513818_256x256.png) | 205 | Aravive Inc. | | 67.78% | -44.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001348911_256x256.png) | 206 | KalVista Pharmaceuticals Inc. | | 66.66% | -125.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000749647_256x256.png) | 207 | Imunon Inc. | | 65.94% | -21.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001526119_256x256.png) | 208 | Verastem Inc. | | 65.75% | 3.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001069899_256x256.png) | 209 | PHIBRO ANIMAL HEALTH CORP | | 64.31% | -9.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001494650_256x256.png) | 210 | OptiNose Inc. | | 61.74% | -68.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 211 | Genprex Inc. | | 59.95% | 100.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001262104_256x256.png) | 212 | MEI Pharma Inc. | | 58.82% | -201.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000059478_256x256.png) | 213 | ELI LILLY & Co | | 57.31% | -1.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 214 | Fibrocell Science Inc. | | 56.46% | 8.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001503802_256x256.png) | 215 | Karyopharm Therapeutics Inc. | | 54.74% | -37.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001555280_256x256.png) | 216 | Zoetis Inc. | | 52.89% | -6.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 217 | Assertio Therapeutics Inc | | 50.55% | -117.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 218 | MELINTA THERAPEUTICS INC. NEW | | 48.97% | -11.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001267565_256x256.png) | 219 | COLLEGIUM PHARMACEUTICAL INC | | 48.24% | -71.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001435049_256x256.png) | 220 | CHINOOK THERAPEUTICS INC. | | 47.23% | -50.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000897448_256x256.png) | 221 | AMARIN CORP PLC\UK | | 47.02% | 64.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000818686_256x256.png) | 222 | TEVA PHARMACEUTICAL INDUSTRIES LTD | | 46.51% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 223 | CELGENE CORP DE | | 45.55% | -18.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001098880_256x256.png) | 224 | IntelGenx Technologies Corp. | | 45.29% | -1.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001343009_256x256.png) | 225 | CNBX Pharmaceuticals Inc. | | 41.55% | -95.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001178879_256x256.png) | 226 | AMICUS THERAPEUTICS INC. | | 39.14% | -157.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001041024_256x256.png) | 227 | ROCKWELL MEDICAL INC. | | 38.21% | -139.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001385508_256x256.png) | 228 | OPIANT PHARMACEUTICALS INC. | | 37.23% | -119.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001723128_256x256.png) | 229 | Amneal Pharmaceuticals Inc. | | 36.61% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001501989_256x256.png) | 230 | CytomX Therapeutics Inc. | | 35.88% | -2.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 231 | Oncternal Therapeutics Inc. | | 35.55% | -87.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001228627_256x256.png) | 232 | Ocuphire Pharma Inc. | | 35.31% | 1.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001583648_256x256.png) | 233 | PIERIS PHARMACEUTICALS INC. | | 35.26% | 10.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000791908_256x256.png) | 234 | XOMA Corp | | 34.87% | -32.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 235 | ACTAVIA LIFE SCIENCES INC. | | 34.46% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001355790_256x256.png) | 236 | International Stem Cell CORP | | 34.20% | 36.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001420720_256x256.png) | 237 | iBio Inc. | | 33.41% | 11.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001395937_256x256.png) | 238 | Syndax Pharmaceuticals Inc | | 30.20% | -100.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001106838_256x256.png) | 239 | Sonnet BioTherapeutics Holdings Inc. | | 29.39% | -31.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001389545_256x256.png) | 240 | NovaBay Pharmaceuticals Inc. | | 28.70% | 27.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001535955_256x256.png) | 241 | Lipocine Inc. | | 28.31% | -53.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 242 | AKORN INC | | 28.02% | -70.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000812796_256x256.png) | 243 | SOLIGENIX INC. | | 25.85% | -40.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001358403_256x256.png) | 244 | BELLICUM PHARMACEUTICALS INC | | 22.63% | -40.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 245 | ALDER BIOPHARMACEUTICALS INC | | 22.14% | -92.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000025743_256x256.png) | 246 | TherapeuticsMD Inc. | | 21.52% | -170.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001671584_256x256.png) | 247 | Aptevo Therapeutics Inc. | | 18.89% | -179.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001103021_256x256.png) | 248 | BIODELIVERY SCIENCES INTERNATIONAL INC | | 18.46% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 249 | Adamas Pharmaceuticals Inc | | 12.41% | -12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001661181_256x256.png) | 250 | Organogenesis Holdings Inc. | | 11.47% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 251 | AILERON THERAPEUTICS INC | | 10.62% | -198.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001689813_256x256.png) | 252 | Biohaven Pharmaceutical Holding Co Ltd. | | 8.70% | -102.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 253 | Flexion Therapeutics Inc | | 8.24% | -85.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001393434_256x256.png) | 254 | OCULAR THERAPEUTIX INC | | 3.13% | 20.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000885590_256x256.png) | 255 | Bausch Health Companies Inc. | | 1.85% | -36.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001444307_256x256.png) | 256 | ONCOSEC MEDICAL Inc | | 1.53% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000890821_256x256.png) | 257 | Enveric Biosciences Inc. | | 1.41% | -51.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001574235_256x256.png) | 258 | Pulmatrix Inc. | | -2.17% | -7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 259 | Teligent Inc. | | -2.67% | -39.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001631574_256x256.png) | 260 | Wave Life Sciences Ltd. | | -2.72% | -123.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001460702_256x256.png) | 261 | Qualigen Therapeutics Inc. | | -6.82% | -210.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001534120_256x256.png) | 262 | Avalo Therapeutics Inc. | | -6.84% | -203.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001340652_256x256.png) | 263 | ChemoCentryx Inc. | | -7.19% | -99.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001014763_256x256.png) | 264 | Ainos Inc. | | -7.55% | -33.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001178711_256x256.png) | 265 | Paratek Pharmaceuticals Inc. | | -11.04% | -49.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001466301_256x256.png) | 266 | Clovis Oncology Inc. | | -14.84% | -57.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001403708_256x256.png) | 267 | Evoke Pharma Inc | | -17.62% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001205922_256x256.png) | 268 | VACCINEX INC. | | -21.80% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001585608_256x256.png) | 269 | Jaguar Health Inc. | | -21.88% | -42.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001401667_256x256.png) | 270 | PUMA BIOTECHNOLOGY INC. | | -22.55% | 24.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001595097_256x256.png) | 271 | Corbus Pharmaceuticals Holdings Inc. | | -25.07% | -181.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001029142_256x256.png) | 272 | DYNAVAX TECHNOLOGIES CORP | | -28.43% | -222.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 273 | SOPHIRIS BIO INC. | | -30.75% | -43.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001061983_256x256.png) | 274 | CYTOKINETICS INC | | -31.08% | -49.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001411685_256x256.png) | 275 | Vistagen Therapeutics Inc. | | -31.32% | 40.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 276 | VIVUS INC | | -32.79% | -19.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 277 | CANNAPHARMARX INC. | | -35.02% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 278 | Neos Therapeutics Inc. | | -35.54% | -2.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001133416_256x256.png) | 279 | GALECTIN THERAPEUTICS INC | | -36.63% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001285819_256x256.png) | 280 | OMEROS CORP | | -39.01% | -146.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001016504_256x256.png) | 281 | INTEGRATED BIOPHARMA INC | | -48.45% | -8.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001509745_256x256.png) | 282 | LEAP THERAPEUTICS INC. | | -48.82% | -7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001100397_256x256.png) | 283 | Ayala Pharmaceuticals Inc. | | -50.05% | -39.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000855654_256x256.png) | 284 | ImmunoGen Inc. | | -51.73% | -13.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001398733_256x256.png) | 285 | Aquestive Therapeutics Inc. | | -53.83% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001270073_256x256.png) | 286 | INTERCEPT PHARMACEUTICALS INC. | | -55.46% | -7.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001062822_256x256.png) | 287 | LEXICON PHARMACEUTICALS INC. | | -55.78% | -33.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 288 | Zyla Life Sciences | | -56.95% | -2.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 289 | PORTOLA PHARMACEUTICALS INC | | -57.03% | -109.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001434868_256x256.png) | 290 | Esperion Therapeutics Inc. | | -63.01% | -182.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 291 | NeuroBo Pharmaceuticals Inc. | | -64.94% | 5.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001442836_256x256.png) | 292 | Mersana Therapeutics Inc. | | -66.20% | -181.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 293 | Dermira Inc. | | -67.95% | -40.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001588972_256x256.png) | 294 | Societal CDMO Inc. | | -68.54% | -48.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001130598_256x256.png) | 295 | Onconova Therapeutics Inc. | | -73.76% | 34.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 296 | Myovant Sciences Ltd. | | -78.23% | -232.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001636050_256x256.png) | 297 | Sio Gene Therapies Inc. | | -79.18% | -68.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001388320_256x256.png) | 298 | Actinium Pharmaceuticals Inc. | | -81.05% | -35.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001429260_256x256.png) | 299 | Fortress Biotech Inc. | | -82.35% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001583771_256x256.png) | 300 | Hepion Pharmaceuticals Inc. | | -84.04% | -58.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001651407_256x256.png) | 301 | Checkpoint Therapeutics Inc. | | -84.55% | -75.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001629205_256x256.png) | 302 | Innovation1 Biotech Inc. | | -86.86% | 22.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001615219_256x256.png) | 303 | Salarius Pharmaceuticals Inc. | | -103.60% | -118.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 304 | BIOVIE INC. | | -104.81% | -86.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001642375_256x256.png) | 305 | Guardion Health Sciences Inc. | | -109.56% | -202.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001410098_256x256.png) | 306 | CorMedix Inc. | | -112.13% | 1.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/mid-up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 307 | First Wave BioPharma Inc. | | -113.44% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001325879_256x256.png) | 308 | AVEO PHARMACEUTICALS INC. | | -125.53% | -6.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001609809_256x256.png) | 309 | Seres Therapeutics Inc. | | -125.62% | -70.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 310 | United Cannabis Corp | | -127.22% | -137.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001390478_256x256.png) | 311 | SELLAS Life Sciences Group Inc. | | -130.48% | -33.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001539029_256x256.png) | 312 | Clearside Biomedical Inc. | | -130.58% | -32.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000822370_256x256.png) | 313 | Emmaus Life Sciences Inc. | | -133.40% | -81.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000715446_256x256.png) | 314 | Anixa Biosciences Inc | | -138.13% | -227.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001061027_256x256.png) | 315 | Viracta Therapeutics Inc. | | -148.14% | -75.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 316 | ADIAL PHARMACEUTICALS INC. | | -161.07% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001001316_256x256.png) | 317 | TG THERAPEUTICS INC. | | -184.56% | -67.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 318 | PROTEO INC | | -189.00% | -8.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001505512_256x256.png) | 319 | Regulus Therapeutics Inc. | | -190.50% | -61.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001017491_256x256.png) | 320 | SEELOS THERAPEUTICS INC. | | -194.75% | -225.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 321 | Axsome Therapeutics Inc. | | -196.86% | -74.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000899460_256x256.png) | 322 | MANNKIND CORP | | -198.78% | -9.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001348362_256x256.png) | 323 | Lexaria Bioscience Corp. | | -202.68% | -251.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 324 | Achaogen Inc. | | -230.97% | -140.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 325 | CARDAX INC. | | -239.08% | -36.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 326 | NORTHWEST BIOTHERAPEUTICS INC | | -240.66% | -18.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001653821_256x256.png) | 327 | CEN BIOTECH INC | | -245.75% | -15.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 328 | ENDONOVO THERAPEUTICS INC. | | -261.92% | -11.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001355250_256x256.png) | 329 | Innovation Pharmaceuticals Inc. | | -263.40% | -30.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 330 | Optec International Inc. | | -274.38% | -138.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 331 | Q BioMed Inc. | | -283.14% | 11.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/up-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 332 | ZEVRA THERAPEUTICS INC. | | -284.80% | -35.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 333 | SANGUI BIOTECH INTERNATIONAL INC | | -292.51% | -12.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 334 | CQENS Technologies Inc. | | -304.99% | -31.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 335 | NANOMIX Corp | | -305.56% | -17.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001641489_256x256.png) | 336 | vTv Therapeutics Inc. | | -314.14% | -27.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 337 | Rebus Holdings Inc. | | -316.29% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001553643_256x256.png) | 338 | RELMADA THERAPEUTICS INC. | | -317.74% | -40.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000737207_256x256.png) | 339 | Adhera Therapeutics Inc. | | -318.72% | -55.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001643301_256x256.png) | 340 | Avenir Wellness Solutions Inc. | | -323.05% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 341 | AXIM BIOTECHNOLOGIES INC. | | -335.57% | -25.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 342 | REGENEREX PHARMA INC. | | -342.77% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000908259_256x256.png) | 343 | Oncotelic Therapeutics Inc. | | -342.82% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 344 | America Great Health | | -365.47% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000832489_256x256.png) | 345 | GeoVax Labs Inc. | | -374.47% | -14.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001133818_256x256.png) | 346 | BIO-PATH HOLDINGS INC | | -375.90% | -211.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 347 | ProtoKinetix Inc. | | -392.97% | -33.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 348 | GlobeStar Therapeutics Corp | | -413.03% | -8.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 349 | RespireRx Pharmaceuticals Inc. | | -416.37% | -14.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 350 | REGENERX BIOPHARMACEUTICALS INC | | -418.03% | -30.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 351 | Regen BioPharma Inc | | -428.15% | -21.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 352 | BIOXYTRAN INC | | -458.82% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001173313_256x256.png) | 353 | ABVC BIOPHARMA INC. | | -470.90% | -52.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 354 | Skye Bioscience Inc. | | -471.97% | -21.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001293310_256x256.png) | 355 | HUMANIGEN INC | | -478.40% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001559356_256x256.png) | 356 | Biostax Corp. | | -489.37% | -22.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 357 | Hoth Therapeutics Inc. | | -522.70% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 358 | Propanc Biopharma Inc. | | -533.82% | -20.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 359 | ARTELO BIOSCIENCES INC. | | -555.91% | -326.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 360 | Rezolute Inc. | | -818.03% | -78.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 361 | Evofem Biosciences Inc. | | -1057.40% | -57.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0000000000_256x256.png) | 362 | Wellness Center USA Inc. | | -1122.34% | -21.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/down-arrows.svg) |
![](https://www.realrate-archive.com/us_pharma/logos/0001622244_256x256.png) | 363 | One World Products Inc. | | -4724.47% | 0.0 | ![](https://realrate.ai/wp-content/themes/flatsome-child/arrows/new-arrows.svg) |